Physician profile
Kim H Thai
NPI 1962839399
$57,017.30
in general payments reported to CMS, 2019-2025
20 companies · $587 in 2025
The $587 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $389 · 2021: $513 · 2022: $52K · 2023: $1,695 · 2024: $1,540 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,326 · Food and Beverage: $1,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,325.77 |
| Food and Beverage | $1,496.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $52,372.11 | 2019-2025 | Ams 700, Lithovue Elite |
| Procept Biorobotics Corporation | $2,253.54 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Teleflex LLC | $802.20 | 2023-2025 | Urolift, Barrigel |
| Coloplast Corp | $460.84 | 2019-2025 | |
| Cook Medical LLC | $171.29 | 2020-2021 | |
| Astellas Pharma US INC | $117.34 | 2021 | |
| Abbvie INC. | $114.47 | 2022-2025 | Botox |
| Pfizer INC. | $112.38 | 2020 | |
| Myriad Genetic Laboratories, INC. | $86.06 | 2021 | |
| Axonics, INC. | $85.36 | 2020-2023 | Bulkamid, Axonics |
| Medtronic USA, INC. | $82.40 | 2020 | |
| Intuitive Surgical, INC. | $73.08 | 2023 | Da Vinci Surgical System |
| Bluewind Medical | $60.00 | 2025 | Revi |
| Antares Pharma, INC. | $50.00 | 2022 | |
| Urogen Pharma, INC. | $45.49 | 2023-2025 | Jelmyto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $33.40 | 2024 | Stratafix |
| 180 Medical, INC. | $27.53 | 2025 | Cure Catheter |
| Novartis Pharmaceuticals Corporation | $24.50 | 2025 | |
| Merck Sharp & Dohme LLC | $22.93 | 2025 | Keytruda |
| Ambu INC. | $22.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Thai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.